Brian Rodrigues - Publications

Global knockout of VEGFB improves lipoprotein lipase activity leading to an improved lipid profile during diabetes.

Journal: Frontiers in pharmacology

Published: December 03, 2025

Cardioprotective effects of a 'twincretin' drug tirzepatide in heart failure following myocardial infarction.

Journal: Cardiovascular research

Published: February 04, 2025

Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Published: April 28, 2024

Heparanase Stimulation of Physiologic Cardiac Hypertrophy Is Suppressed After Chronic Diabetes, Resulting in Cardiac Remodeling and Dysfunction.

Journal: Diabetes

Published: March 15, 2024

Reduction in Insulin Uncovers a Novel Effect of VEGFB on Cardiac Substrate Utilization.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: December 27, 2023

Downregulation of adipose LPL by PAR2 contributes to the development of hypertriglyceridemia.

Journal: JCI insight

Published: June 21, 2023

Flow-Induced Secretion of Endothelial Heparanase Regulates Cardiac Lipoprotein Lipase and Changes Following Diabetes.

Journal: Journal of the American Heart Association

Published: November 23, 2022

Cardiac-specific VEGFB overexpression reduces lipoprotein lipase activity and improves insulin action in rat heart.

Journal: American journal of physiology. Endocrinology and metabolism

Published: November 08, 2021

Lipoprotein Lipase and Its Delivery of Fatty Acids to the Heart.

Journal: Biomolecules

Published: June 05, 2021

Involvement of Heparanase in Endothelial Cell-Cardiomyocyte Crosstalk.

Journal: Advances in experimental medicine and biology

Published: April 11, 2020

Loss of function of transcription factor EB remodels lipid metabolism and cell death pathways in the cardiomyocyte.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: December 18, 2019

Diabetes Mellitus Severity and a Switch From Using Lipoprotein Lipase to Adipose-Derived Fatty Acid Results in a Cardiac Metabolic Signature That Embraces Cell Death.

Journal: Journal of the American Heart Association

Published: November 01, 2019